Paradoxical adipose hyperplasia happens. Here’s what to do when it happens to your cryolipolosis patients.
Patients who are not candidates for liposuction or excisional body sculpting procedures have fallen into a treatment gap — until now.
Cutera’s latest technology, truSculpt iD claims speed, comfort and full abdominal sculpting in 15 minutes.
Among the array of safe and effective non- and minimally invasive therapies available to physicians using the expandable JOULE™ platform from Sciton (Palo Alto, California, U.S.), the treatment of scars and acne scarring is one of the more useful and commonly sought. Its 2940 Er:YAG laser is ideal for this indication, especially in Asian skin.
When Merz North America (Raleigh, N.C.) announced a new marketing campaign for Xeomin® (incobotulinumtoxinA) and Ultherapy®, in partnership with supermodel, actress and celebrity entrepreneur Christie Brinkley in October 2017, it solidified a bold new business strategy. This strategy has, in turn, strengthened the company’s market position by increasing brand awareness, while disrupting the medical aesthetic industry.
From fine lines and wrinkles to uneven pigment and unwanted tattoos, enlighten by Cutera (Brisbane, California, U.S.) offers treatment versatility. Its 532 nm and 1064 nm wavelengths operate at pulse durations of 2 ns or 750 ps; while its 670 nm wavelength delivers energy at 660 picoseconds.
With four Q-switched wavelengths, the StarWalker by Fotona (Ljubljana, Slovenia) allows operators to safely treat a variety of pigment problems and tattoos, in addition to benign and vascular lesions and the appearance of aging skin.
Dr. Val Lambros separates illusion from reality in a recent study.
As demand for energy-based anti-aging procedures continues to rise, practitioners are faced with choosing from a wide array of aesthetic platforms and devices. Five experts share insights on how to differentiate.
Microneedling has come of age in the medical aesthetic arena as SkinPen® from Bellus Medical (Addison, Texas) recently announced that it is the first and only microneedling system to receive a De Novo clearance as a Class II medical device by The Food and Drug Administration (FDA). This designation grants the company clearance and marketing authorization for the device, which is intended to improve the appearance of facial acne scars in adults aged 22 years or older. This clearance was based on the FDA’s recently codified language regarding aesthetic uses of microneedling.